Global, regional and national burden of Metabolic dysfunction-associated steatotic liver disease in adolescents and adults aged 15–49 years from 1990 to 2021: results from the 2021 Global Burden of Disease study

Over the past three decades, the global burden of MASLD has risen significantly, especially in regions with rapidly increasing obesity rates. Despite progress in some high-income countries, the persistent escalation in low-income regions underscores the urgency for targeted interventions.